Dr Mary Ann Anderson

Dr Mary Ann Anderson

left-column

headshot-wrapper

Dr Mary Ann Anderson in the lab

the-headshot-content

Dr
Mary Ann
Anderson

MBBS Melbourne FRACP FRCPA

PhD Student

I am a clinician scientist focusing on new treatments for leukaemia and lymphoma. I study potential anti-cancer agents that target proteins keep cancer cells alive. The long term goal is to develop better treatments for people with cancer, without the serious side effects of chemotherapy.

Research interest

My PhD research has focused on the BH3 mimetic agent, ABT-199, assessing it as a potential new treatment for people with certain leukaemias and lymphomas. I conduct laboratory studies to assess ABT-199’s effects on leukaemia and lymphoma cells. As a haematologist I am involved in clinical studies investigating ABT-199 as a potential new anti-cancer agent.